Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
$0.00
$0.00
$0.00
N/A-0.137,250 shs50,000 shs
HDVY
Health Discovery
$0.00
$0.00
$0.00
N/A1.271,000 shsN/A
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
$0.00
$0.00
$0.00
N/AN/AN/AN/A
UPDC
Esio Water and Beverage Development
$0.00
$0.00
$0.00
N/A-0.181,000 shsN/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
0.00%0.00%0.00%0.00%0.00%
HDVY
Health Discovery
0.00%0.00%0.00%0.00%0.00%
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
0.00%0.00%0.00%0.00%0.00%
UPDC
Esio Water and Beverage Development
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
HDVY
Health Discovery
N/AN/AN/AN/AN/AN/AN/AN/A
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
UPDC
Esio Water and Beverage Development
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
0.00
N/AN/AN/A
HDVY
Health Discovery
0.00
N/AN/AN/A
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
0.00
N/AN/AN/A
UPDC
Esio Water and Beverage Development
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
N/AN/AN/AN/AN/AN/A
HDVY
Health Discovery
N/AN/AN/AN/AN/AN/A
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
N/AN/AN/AN/AN/AN/A
UPDC
Esio Water and Beverage Development
$40KN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
N/AN/A0.00N/AN/AN/AN/AN/AN/A
HDVY
Health Discovery
N/AN/A0.00N/AN/AN/AN/AN/AN/A
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
N/AN/A0.00N/AN/AN/AN/AN/AN/A
UPDC
Esio Water and Beverage Development
-$1.21MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
N/AN/AN/AN/AN/A
HDVY
Health Discovery
N/AN/AN/AN/AN/A
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
N/AN/AN/AN/AN/A
UPDC
Esio Water and Beverage Development
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Decision Diagnostics Corp. stock logo
DECN
Decision Diagnostics
5N/AN/ANot Optionable
HDVY
Health Discovery
3420.33 million284.99 millionNot Optionable
NutraLife Biosciences, Inc. stock logo
NLBS
NutraLife Biosciences
10N/AN/ANot Optionable
UPDC
Esio Water and Beverage Development
3N/AN/ANot Optionable

Media Sentiment Over Time

Decision Diagnostics stock logo

Decision Diagnostics OTCMKTS:DECN

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.

Health Discovery OTCMKTS:HDVY

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. Its intellectual property includes Support Vector Machines (SVM), which are mathematical algorithms; and biomarkers that are biological indicators or genetic expression signatures of certain disease states, as well as Fractal Genomic Modeling technology. The company was incorporated in 2001 and is based in Atlanta, Georgia.

NutraLife Biosciences stock logo

NutraLife Biosciences OTCMKTS:NLBS

NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.

Esio Water and Beverage Development OTCMKTS:UPDC

UPD Holding Corp. does not have significant operations. Previously, the company was operated in the food and beverage industry in the United States. It intends to acquire assets and businesses in the rehabilitation services industry. The company was founded in 2013 and is based in Reno, Nevada.